Vaccines, virucides and drugs against HIV/AIDS: Hopes and optimisms for the future

Open AIDS Journal

Volumn 3, Issue , 2009, Pages 1-3

  Al Jabri, A A ^a   Alenzi, F Q ^b  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

AIDS; Drugs; HIV; Immune response; Vaccines; Virucides

Indexed keywords

ANTIVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CIRCUMCISION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; PRIORITY JOURNAL; SEXUAL TRANSMISSION; VACCINATION; VIRUS TRANSMISSION;

EID: 76749093205     PISSN: None     EISSN: 18746136     Source Type: Journal    
DOI: 10.2174/1874613600903010001     Document Type: Article

References (12)

1. Senior K. Back to basics for HIV vaccine research. Lancet Infect Dis 2008; 8: 467.
2. Kersh EN, Luo W, Adams DR, et al. Short communication: no evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques. AIDS Res Hum Retroviruses 2008; 24: 543-546 (Pubitemid 351571040)
3. Johnston MI, Fauci AS. An HIV vaccine--challenges and prospects. N Engl J Med 2008; 359: 888-890
4. Fauci AS, Johnston MI, Dieffenbach CW, et al. HIV vaccine research: the way forward. Science 2008; 321: 530-532
5. Al-Jabri AA. HIV/AIDS vaccines. How long must humanity wait? Sultan Qaboos Univ Med J 2007; 7: 193-195
6. Al-Jabri AA, Wigg MD, Elias E, Lambkin R, Mills CO, Oxford JS. In vitro anti-HIV-1 virucidal activity of tyrosine conjugated tri and dihydroxy bile salt derivatives. J Antimicrob Chemother 2000; 45: 617-621
7. Wilson DP, Coplan PM, Wainberg MA, Blower SM. The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics. Proc Natl Acad Sci USA 2008; 105: 9835-9840
8. Food and Drug Administration, HHS. Over-the-counter vaginal contraceptive and spermicide drug products containing nonoxynol 9; required labeling. Final rule. Fed Regist 2007; 72: 71769-71785
9. Grant RM, Hamer D, Hope T, et al. Whither or wither microbicides? Science 2008; 321: 532-534
10. Blankson J, Persaud D, Siliciano R. The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med 2002; 53: 557-593 (Pubitemid 34177896)
11. Haynes BF, Shattock RJ. Critical issues in mucosal immunity for HIV-1 vaccine development. J Allergy Clin Immunol 2008; 122: 3-9.
12. Huan, J, Wang F, Argyris E, et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 2007; 12: 1241-1247 (Pubitemid 47530631)